Host: |
Rabbit |
Applications: |
WB/ELISA |
Reactivity: |
Human/Mouse/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.01% Thimerosal, 50% Glycerol, pH 7.3. |
Purification: |
Affinity purification |
Concentration: |
Lot specific |
Dilution Range: |
WB:1:500-1:2000ELISA:Recommended starting concentration is 1 Mu g/mL. Please optimize the concentration based on your specific assay requirements. |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
PARP12 |
Gene ID: |
64761 |
Uniprot ID: |
PAR12_HUMAN |
Immunogen Region: |
462-701 |
Specificity: |
Recombinant fusion protein containing a sequence corresponding to amino acids 462-701 of human PARP12 (NP_073587.1). |
Immunogen Sequence: |
YVSPQDVTTMQTCNTKFPGP KSIPDYWDSSALPDPGFQKI TLSSSSEEYQKVWNLFNRTL PFYFVQKIERVQNLALWEVY QWQKGQMQKQNGGKAVDERQ LFHGTSAIFVDAICQQNFDW RVCGVHGTSYGKGSYFARDA AYSHHYSKSDTQTHTMFLAR VLVGEFVRGNASFVRPPAKE GWSNAFYDSCVNSVSDPSIF VIFEKHQVYPEYVIQYTTSS KPSVTPSILLALGSLFSSR |
Post Translational Modifications | Auto-mono-ADP-ribosylated. |
Function | Mono-ADP-ribosyltransferase that mediates mono-ADP-ribosylation of target proteins. |
Protein Name | Protein Mono-Adp-Ribosyltransferase Parp12Adp-Ribosyltransferase Diphtheria Toxin-Like 12Artd12Poly Adp-Ribose Polymerase 12Parp-12Zinc Finger Ccch Domain-Containing Protein 1 |
Cellular Localisation | Nucleus |
Alternative Antibody Names | Anti-Protein Mono-Adp-Ribosyltransferase Parp12 antibodyAnti-Adp-Ribosyltransferase Diphtheria Toxin-Like 12 antibodyAnti-Artd12 antibodyAnti-Poly Adp-Ribose Polymerase 12 antibodyAnti-Parp-12 antibodyAnti-Zinc Finger Ccch Domain-Containing Protein 1 antibodyAnti-PARP12 antibodyAnti-ZC3HDC1 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance